학술논문

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
Document Type
Article
Source
Arthritis Research & Therapy; 1/5/2022, Vol. 24 Issue 1, p1-15, 15p
Subject
Language
ISSN
14786354